IPQ Inside the global regulatory dialogue

Preparing for CMC Changes is Difficult but Pivotal to Accelerating CGT Development, Industry Experts Are Stressing

Oct 2nd, 2019

Please Log in to print the full article

Prioritize Changes That Can Be Made Before Pivotal Trials Prior to joining Celgene in March 2018, where she focuses on late-phase CAR-T product CMC, Momonoi played a lead role in late-stage process development of CGTs...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2020 IPQ Publications